Law firm Winston & Strawn represented Clear Street in connection with Helius Medical Technologies’ recently announced $500 million oversubscribed PIPE offering, consisting of units of common stock and stapled warrants to purchase additional shares. The units were priced at $6.881 each, with stapled warrants exercisable over three years at $10.134 per share.
The offering is led by Pantera Capital and Summer Capital, with participation from other investors, and includes up to an additional $750 million in warrants. Closing is expected on or about Sept. 18, 2025, subject to customary conditions. Helius intends to use the proceeds to implement a digital asset treasury strategy and acquire SOL, the native token of the Solana blockchain, as its primary treasury reserve asset.
The Winston & Strawn team advising Clear Street was led by Mike Blankenship, managing partner of the firm’s Houston office, along with associates Riley Doggett and Jordan Saddoris.
